These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15222127)

  • 1. Cytopathological basis of heart failure--cardiomyocyte apoptosis, interstitial fibrosis and inflammatory cell response.
    Petrovic D
    Folia Biol (Praha); 2004; 50(2):58-62. PubMed ID: 15222127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Programmed cell death in the progression of heart failure.
    Sabbah HN; Sharov VG; Goldstein S
    Ann Med; 1998 Aug; 30 Suppl 1():33-8. PubMed ID: 9800881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell death, tissue hypoxia and the progression of heart failure.
    Sabbah HN; Sharov VG; Goldstein S
    Heart Fail Rev; 2000 Jun; 5(2):131-8. PubMed ID: 16228140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phenotype alterations of failing myocardium].
    Takemura G; Fujiwara H
    Nihon Rinsho; 2003 May; 61(5):731-8. PubMed ID: 12754995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart.
    Wang G; Hamid T; Keith RJ; Zhou G; Partridge CR; Xiang X; Kingery JR; Lewis RK; Li Q; Rokosh DG; Ford R; Spinale FG; Riggs DW; Srivastava S; Bhatnagar A; Bolli R; Prabhu SD
    Circulation; 2010 May; 121(17):1912-25. PubMed ID: 20404253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-apoptosis in nonmyocytes and pro-autophagy in cardiomyocytes: two strategies against postinfarction heart failure through regulation of cell death/degeneration.
    Takemura G; Kanamori H; Okada H; Miyazaki N; Watanabe T; Tsujimoto A; Goto K; Maruyama R; Fujiwara T; Fujiwara H
    Heart Fail Rev; 2018 Sep; 23(5):759-772. PubMed ID: 29737434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell death in acromegalic cardiomyopathy.
    Frustaci A; Chimenti C; Setoguchi M; Guerra S; Corsello S; Crea F; Leri A; Kajstura J; Anversa P; Maseri A
    Circulation; 1999 Mar; 99(11):1426-34. PubMed ID: 10086965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Cardiac Resynchronization Therapy on Myocardial Fibrosis and Relevant Cytokines in a Canine Model With Experimental Heart Failure.
    Wang J; Gong X; Chen H; Qin S; Zhou N; Su Y; Ge J
    J Cardiovasc Electrophysiol; 2017 Apr; 28(4):438-445. PubMed ID: 28127817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fibrosis-cell death axis in heart failure.
    Piek A; de Boer RA; Silljé HH
    Heart Fail Rev; 2016 Mar; 21(2):199-211. PubMed ID: 26883434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ecto-5'-nucleotidase deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction.
    Xu X; Fassett J; Hu X; Zhu G; Lu Z; Li Y; Schnermann J; Bache RJ; Chen Y
    Hypertension; 2008 Jun; 51(6):1557-64. PubMed ID: 18391093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiomyocyte apoptosis in the failing heart--a critical review from definition and classification of cell death.
    Takemura G; Kanoh M; Minatoguchi S; Fujiwara H
    Int J Cardiol; 2013 Sep; 167(6):2373-86. PubMed ID: 23498286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketone Ester Treatment Improves Cardiac Function and Reduces Pathologic Remodeling in Preclinical Models of Heart Failure.
    Yurista SR; Matsuura TR; Silljé HHW; Nijholt KT; McDaid KS; Shewale SV; Leone TC; Newman JC; Verdin E; van Veldhuisen DJ; de Boer RA; Kelly DP; Westenbrink BD
    Circ Heart Fail; 2021 Jan; 14(1):e007684. PubMed ID: 33356362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NOD1 activation induces cardiac dysfunction and modulates cardiac fibrosis and cardiomyocyte apoptosis.
    Fernández-Velasco M; Prieto P; Terrón V; Benito G; Flores JM; Delgado C; Zaragoza C; Lavin B; Gómez-Parrizas M; López-Collazo E; Martín-Sanz P; Boscá L
    PLoS One; 2012; 7(9):e45260. PubMed ID: 23028889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hippo Deficiency Leads to Cardiac Dysfunction Accompanied by Cardiomyocyte Dedifferentiation During Pressure Overload.
    Ikeda S; Mizushima W; Sciarretta S; Abdellatif M; Zhai P; Mukai R; Fefelova N; Oka SI; Nakamura M; Del Re DP; Farrance I; Park JY; Tian B; Xie LH; Kumar M; Hsu CP; Sadayappan S; Shimokawa H; Lim DS; Sadoshima J
    Circ Res; 2019 Jan; 124(2):292-305. PubMed ID: 30582455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A state of reversible compensated ventricular dysfunction precedes pathological remodelling in response to cardiomyocyte-specific activity of angiotensin II type-1 receptor in mice.
    Frentzou GA; Drinkhill MJ; Turner NA; Ball SG; Ainscough JF
    Dis Model Mech; 2015 Aug; 8(8):783-94. PubMed ID: 26092119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis in heart failure: a real problem?
    Sabbah HN
    Cardiovasc Drugs Ther; 2001 Nov; 15(6):525-8. PubMed ID: 11916361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased passive stiffness promotes diastolic dysfunction despite improved Ca2+ handling during left ventricular concentric hypertrophy.
    Røe ÅT; Aronsen JM; Skårdal K; Hamdani N; Linke WA; Danielsen HE; Sejersted OM; Sjaastad I; Louch WE
    Cardiovasc Res; 2017 Aug; 113(10):1161-1172. PubMed ID: 28472418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of heart failure following myocardial infarction.
    Struthers AD
    Heart; 2005 May; 91 Suppl 2(Suppl 2):ii14-6; discussion ii31, ii43-8. PubMed ID: 15831601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional diastolic dysfunction in post-infarction heart failure: role of local mechanical load and SERCA expression.
    Røe ÅT; Ruud M; Espe EK; Manfra O; Longobardi S; Aronsen JM; Nordén ES; Husebye T; Kolstad TRS; Cataliotti A; Christensen G; Sejersted OM; Niederer SA; Andersen GØ; Sjaastad I; Louch WE
    Cardiovasc Res; 2019 Mar; 115(4):752-764. PubMed ID: 30351410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis in hypertensive heart disease.
    Díez J; Fortuño MA; Ravassa S
    Curr Opin Cardiol; 1998 Sep; 13(5):317-25. PubMed ID: 9823788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.